SEC 13F Intelligence

Artal Group S.A. / NMRA

Artal Group S.A.’s Neumora Therapeutics Inc. Position

Does Artal Group S.A. own Neumora Therapeutics Inc. (NMRA)? Not currently — the last reported position was 2.82M shares worth $28M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$28M
Q2 2024
Shares
2.82M
% of Portfolio
+0.71%
Quarters Held
4
position exited

Position History NMRA

Reported value by quarter
Q3 ’23: $39,546Q3 ’23Q4 ’23: $43,524Q4 ’23Q1 ’24: $40MQ1 ’24Q2 ’24: $28MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20242.82M$28M+0.71%
Q1 20242.92M$40M+1.02%
Q4 20232.55M$43,524+1.45%
Q3 20232.80M$39,546+1.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artal Group S.A.’s full portfolio or all institutional holders of NMRA.